Scientists have made a discovery about the bacterial code behind certain anti-cancer drugs, which could potentially lead to the development of new and improved cancer treatments. The findings involve a "mix-and-match" mechanism that may allow for the creation of new cancer-fighting compounds. It is unclear if this discovery is related to a specific bacterium or cancer treatment, as reports mention various aspects of the research, including its potential application to colorectal tumors and rectal cancer.